Johnson Investment Counsel Inc Becton Dickinson & CO Transaction History

Johnson Investment Counsel Inc

  • $10.1 Billion
  • Q3 2024

A detailed history of Johnson Investment Counsel Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 17,430 shares of BDX stock, worth $3.98 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
17,430
Previous 15,973 9.12%
Holding current value
$3.98 Million
Previous $3.73 Million 12.56%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$221.47 - $242.41 $322,681 - $353,191
1,457 Added 9.12%
17,430 $4.2 Million
Q2 2024

Aug 08, 2024
BUY
$225.07 - $246.17 $22,056 - $24,124
98 Added 0.62%
15,973 $3.73 Million
Q1 2024

May 09, 2024
BUY
$233.45 - $247.73 $122,561 - $130,058
525 Added 3.42%
15,875 $3.93 Million
Q4 2023

Feb 07, 2024
SELL
$232.24 - $267.23 $130,983 - $150,717
-564 Reduced 3.54%
15,350 $3.74 Million
Q3 2023

Nov 13, 2023
SELL
$254.9 - $283.59 $43,078 - $47,926
-169 Reduced 1.05%
15,914 $4.11 Million
Q2 2023

Aug 10, 2023
SELL
$238.39 - $265.32 $49,108 - $54,655
-206 Reduced 1.26%
16,083 $4.25 Million
Q1 2023

May 15, 2023
BUY
$229.71 - $259.35 $26,186 - $29,565
114 Added 0.7%
16,289 $4.03 Million
Q4 2022

Feb 14, 2023
SELL
$218.29 - $256.91 $29,687 - $34,939
-136 Reduced 0.83%
16,175 $4.11 Million
Q3 2022

Nov 14, 2022
SELL
$51.03 - $264.23 $41,538 - $215,083
-814 Reduced 4.75%
16,311 $3.64 Million
Q2 2022

Aug 15, 2022
BUY
$234.74 - $275.42 $144,834 - $169,934
617 Added 3.74%
17,125 $4.22 Million
Q1 2022

May 11, 2022
SELL
$243.64 - $270.48 $209,530 - $232,612
-860 Reduced 4.95%
16,508 $4.39 Million
Q4 2021

Feb 15, 2022
SELL
$230.08 - $250.94 $209,142 - $228,104
-909 Reduced 4.97%
17,368 $4.37 Million
Q3 2021

Nov 12, 2021
SELL
$232.72 - $256.47 $86,804 - $95,663
-373 Reduced 2.0%
18,277 $4.49 Million
Q2 2021

Aug 13, 2021
SELL
$232.65 - $254.58 $13,959 - $15,274
-60 Reduced 0.32%
18,650 $4.54 Million
Q1 2021

May 14, 2021
SELL
$232.09 - $256.88 $761,951 - $843,337
-3,283 Reduced 14.93%
18,710 $4.55 Million
Q4 2020

Feb 12, 2021
SELL
$221.92 - $245.94 $350,855 - $388,831
-1,581 Reduced 6.71%
21,993 $5.5 Million
Q3 2020

Nov 16, 2020
SELL
$215.77 - $276.76 $311,140 - $399,087
-1,442 Reduced 5.76%
23,574 $5.49 Million
Q2 2020

Aug 13, 2020
SELL
$219.9 - $263.41 $242,769 - $290,804
-1,104 Reduced 4.23%
25,016 $5.99 Million
Q1 2020

May 20, 2020
SELL
$195.69 - $279.01 $355,960 - $507,519
-1,819 Reduced 6.51%
26,120 $6 Million
Q4 2019

Feb 13, 2020
SELL
$236.45 - $266.82 $83,230 - $93,920
-352 Reduced 1.24%
27,939 $7.6 Million
Q3 2019

Nov 14, 2019
SELL
$230.58 - $256.08 $510,965 - $567,473
-2,216 Reduced 7.26%
28,291 $7.16 Million
Q2 2019

Aug 14, 2019
SELL
$217.4 - $246.08 $148,701 - $168,318
-684 Reduced 2.19%
30,507 $7.69 Million
Q1 2019

May 13, 2019
SELL
$206.05 - $248.17 $291,560 - $351,160
-1,415 Reduced 4.34%
31,191 $7.79 Million
Q4 2018

Feb 13, 2019
BUY
$204.73 - $257.93 $72,679 - $91,565
355 Added 1.1%
32,606 $7.35 Million
Q3 2018

Nov 14, 2018
SELL
$233.07 - $256.0 $626,259 - $687,872
-2,687 Reduced 7.69%
32,251 $8.42 Million
Q2 2018

Aug 14, 2018
BUY
$208.1 - $233.85 $574,772 - $645,893
2,762 Added 8.58%
34,938 $8.37 Million
Q1 2018

May 15, 2018
BUY
$205.46 - $240.27 $614,736 - $718,887
2,992 Added 10.25%
32,176 $6.97 Million
Q4 2017

Feb 14, 2018
SELL
$189.0 - $222.64 $44,982 - $52,988
-238 Reduced 0.81%
29,184 $6.25 Million
Q3 2017

Nov 14, 2017
BUY
$186.89 - $198.9 $5.5 Million - $5.85 Million
29,422
29,422 $5.77 Million

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email